Findings from a multi-center, international clinical trial reported by a Cleveland Clinic physician show that semaglutide reduced cardiovascular events by 20 percent in adults with overweight or obesity and established cardiovascular disease who don’t hav

In the first-in-human phase 1 trial of lepodisiran, a novel short-interfering RNA (siRNA) therapy, levels of lipoprotein(a) (Lp(a)) were reduced below the lowest limit of quantitation for nearly nine months. Steven Nissen, MD, summarizes these findings th

Following a case presentation, Mazen Hanna, MD, Co-Director of the Cleveland Clinic's Amyloidosis Center, provides an overview of ATTR Amyloidosis, reviewing pathophysiology and types.

Treatment and management of infective endocarditis (IE) requires a multidisciplinary approach. Steven Gordon, MD, provides an overview of medical management of IE from an infectious disease lens.

In this episode Bo Xu, MD, discusses multimodality imaging to evaluate suspected infective endocarditis. Haytham Elgharably, MD, provides an overview and reviews indications and optimal timing for cardiac surgery.

There are many considerations for patients requiring reoperation. Marc Gillinov, MD, Faisal Bakaeen, MD, and Shinya Unai, MD, discuss some of these considerations as well as what has led to Cleveland Clinic's success.

Marc Gillinov, MD, Chairman of the Department of Thoracic and Cardiovascular Surgery in the Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute, provides an overview and update on Cardiovascular and Thoracic Surgery at Cleveland Clini

The field of research is continually developing and evolving. One specific area relates to inclusion and exclusion criteria for participants. Eileen Hsich, MD, discusses the importance of recruiting diverse patients.

Sudish Murthy, MD, PhD, provides a Thoracic Surgery Robotics update at Cleveland Clinic's Heart, Vascular and Thoracic Institute.

Oussama Wazni, MD, MBA, and Pasquale Santangeli, MD, PhD, from the Cardiac Electrophysiology and Pacing Section, discuss considerations for managing ventricular tachycardia as a result from cardiomyopathy.